RBB Fund, Inc. (LFSC)
Management Company · XNAS · Series S000088167 · View on SEC EDGAR ↗
$35.21
As of March 10, 2026
▲ +0.22 (+0.62%)
1-day change
$18.78 – $40.10
52-week range
- Net assets
- $105.1M
- Holdings
- 40
- As of
- May 31, 2026
- Top 10 holdings weight
- 54.73%
- Effective number of positions
- 23.8
- Positions above 1%
- 29
On this page
- Price chart The fund's market price over time, with technical overlays.
- Performance Total return, volatility, drawdown and other risk metrics.
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
LFSC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
Performance as of March 10, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -2.10% | — |
| 3M | ▼ -10.51% | — |
| 6M | ▲ +21.69% | — |
| YTD | ▼ -3.83% | — |
| 1Y | ▲ +60.62% | — |
| 3Y | — | — |
| 5Y | — | — |
| Max since Oct. 31, 2024 | ▲ +41.48% | — |
- Volatility 1Y
- 28.58%
- Volatility 3Y
- —
- Max drawdown 3Y
- —
- Beta 3Y
- —
- Sharpe 1Y*
- 1.82
Total return is shown once dividend history for this fund has been collected — price return alone would duplicate it misleadingly. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
- Last month (May 2026)
- -$129K
- Quarter ending May 2026
- +$1.2M
- Trailing 12 months
- +$14.3M
Jun 2025 – May 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 40 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| Travere Therapeutics Inc | 89422G107 | $8.1M | 7.67 | 170,714 | EC | US |
| Cogent Biosciences Inc | 19240Q201 | $7.9M | 7.53 | 226,142 | EC | US |
| LivaNova PLC | — | $7.5M | 7.11 | 101,212 | EC | GB |
| Spyre Therapeutics Inc | 00773J202 | $6.7M | 6.41 | 91,588 | EC | US |
| Guardant Health Inc | 40131M109 | $5.8M | 5.52 | 44,694 | EC | US |
| Mirum Pharmaceuticals Inc | 604749101 | $5.2M | 4.92 | 50,911 | EC | US |
| Corcept Therapeutics Inc | 218352102 | $5.0M | 4.79 | 72,454 | EC | US |
| United Therapeutics Corp | 91307C102 | $4.4M | 4.16 | 7,841 | EC | US |
| VeraDermics Inc | 922967104 | $3.6M | 3.42 | 35,568 | EC | US |
| Savara Inc | 805111101 | $3.4M | 3.22 | 651,024 | EC | US |
| Cytokinetics Inc | 23282W605 | $3.3M | 3.16 | 43,268 | EC | US |
| Nektar Therapeutics | 640268306 | $3.3M | 3.14 | 50,876 | EC | US |
| Trevi Therapeutics Inc | 89532M101 | $3.3M | 3.12 | 231,602 | EC | US |
| Dianthus Therapeutics Inc | 252828108 | $3.2M | 3.09 | 34,884 | EC | US |
| Axsome Therapeutics Inc | 05464T104 | $3.0M | 2.84 | 12,723 | EC | US |
| Billiontoone Inc | 090168105 | $2.9M | 2.73 | 29,023 | EC | US |
| TransMedics Group Inc | 89377M109 | $2.8M | 2.68 | 41,894 | EC | US |
| Viridian Therapeutics Inc | 92790C104 | $2.3M | 2.23 | 133,261 | EC | US |
| ICU Medical Inc | 44930G107 | $2.2M | 2.09 | 16,227 | EC | US |
| Corvus Pharmaceuticals Inc | 221015100 | $2.1M | 1.95 | 165,305 | EC | US |
| Palvella Therapeutics Inc | 697947109 | $2.0M | 1.95 | 17,254 | EC | US |
| Ceribell Inc | 15678C102 | $1.6M | 1.55 | 88,354 | EC | US |
| Globus Medical Inc | 379577208 | $1.3M | 1.27 | 16,258 | EC | US |
| Xeris Biopharma Holdings Inc | 98422E103 | $1.3M | 1.22 | 207,543 | EC | US |
| Bridgebio Pharma Inc | 10806X102 | $1.2M | 1.17 | 18,534 | EC | US |
| Integer Holdings Corp | 45826H109 | $1.2M | 1.14 | 13,436 | EC | US |
| Twist Bioscience Corp | 90184D100 | $1.2M | 1.14 | 17,850 | EC | US |
| F/m Ultrashort Treasury Inflat | 74933W213 | $1.1M | 1.08 | 22,751 | EC | US |
| Waystar Holding Corp | 946784105 | $1.1M | 1.05 | 55,155 | EC | US |
| WaVe Life Sciences Ltd | — | $1.0M | 0.95 | 152,008 | EC | SG |
| Hinge Health Inc | 433313103 | $989K | 0.94 | 17,590 | EC | US |
| Korro Bio Inc | 500946108 | $843K | 0.80 | 62,855 | EC | US |
| RadNet Inc | 750491102 | $827K | 0.79 | 14,899 | EC | US |
| Aveanna Healthcare Holdings In | 05356F105 | $758K | 0.72 | 105,779 | EC | US |
| Lumexa Imaging Holdings Inc | 550249106 | $739K | 0.70 | 94,977 | EC | US |
| Insmed Inc | 457669307 | $647K | 0.62 | 6,050 | EC | US |
| Alphatec Holdings Inc | 02081G201 | $600K | 0.57 | 77,386 | EC | US |
| NeoGenomics Inc | 64049M209 | $453K | 0.43 | 43,071 | EC | US |
| Alamar Biosciences Inc | 010911105 | $193K | 0.18 | 9,442 | EC | US |
| U.S. Bank Money Market Deposit Account | 8AMMF0A92 | $203 | 0.00 | 203 | STIV | US |
Sector breakdown
Healthcare
90.0%
Other/Unmapped
10.0%
Institutional owners (13F) 8 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| EMERALD MUTUAL FUND ADVISERS TRUST | $90,272,572 | 92.77% | 1,997,035 | Shares | June 30, 2026 |
| SBE LLC DBA CEDAR COVE WEALTH PARTNERS | $3,169,927 | 3.26% | 70,126 | Shares | June 30, 2026 |
| Atria Investments, Inc | $1,107,752 | 1.14% | 24,506 | Shares | June 30, 2026 |
| IHT Wealth Management, LLC | $1,107,752 | 1.14% | 24,506 | Shares | June 30, 2026 |
| Old Port Advisors | $1,022,182 | 1.05% | 22,613 | Shares | June 30, 2026 |
| Toroso Investments, LLC | $622,596 | 0.64% | 17,004 | Shares | Dec. 31, 2025 |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | $2,611 | 0.00% | 57,742 | Shares | June 30, 2026 |
| FMR LLC | $1,356 | 0.00% | 30 | Shares | June 30, 2026 |
Peer funds
Similar by size
| Fund | AUM |
|---|---|
| SEPT AIM ETF Products Trust | $105.1M |
| SMCY Tidal Trust II | $105.7M |
| ROAM Lattice Strategies Trust | $106.0M |
| SMCX Tidal Trust II | $106.1M |
| SAUG First Trust Exchange-Traded Fun… | $106.1M |
| AMID EA Series Trust | $105.0M |
| AOTG EA Series Trust | $104.9M |
| RIET ETF Series Solutions | $104.5M |
| CHAU Direxion Shares ETF Trust | $104.1M |
| PRSD SSGA Active Trust | $104.0M |